Fulgent Genetics, Inc. (FLGT) vs Faeth Therapeutics, Inc. (FTH)

A side-by-side comparison of Fulgent Genetics, Inc. and Faeth Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FLGT vs FTH

growth of $100 · dividends reinvested · last 6y
FLGT -80.1% (-23.6%/yr)FTH -92.8% (-35.5%/yr)FLGT compounded faster over this window
050100150Start $10020222023202420252026$20$7
FLGT FTH

FLGT vs FTH: by the numbers

  • •FTH is the larger company ($699M vs $638M market cap).
  • •Both run net losses; FTH's is the smaller (0.00% vs -26.05% net margin).

Metrics side by side

Valuation

MetricFLGTFTH
P/S ratio1.97N/A
P/B ratio0.644.04

Profitability

MetricFLGTFTH
Gross margin35.58%0.00%
Operating margin-28.23%0.00%
Net margin-26.05%0.00%
ROE-8.42%-113.05%
ROIC-11.80%-110.62%

Growth (annualized)

MetricFLGTFTH
Revenue CAGR (5Y)-18.66%N/A
Total return CAGR (5Y)-22.38%-31.75%

Frequently asked

How have FLGT and FTH total returns compared?
Over the past 5 years, FLGT delivered -22.38% and FTH delivered -31.75% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.